| Patents for C07D 317 - Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms (18,224) |
|---|
| 09/30/2004 | WO2004083153A1 Process for manufacture of an allyl ether |
| 09/30/2004 | WO2004082677A1 Substituted p-diaminobenzene derivatives |
| 09/30/2004 | WO2003072535A8 Substituted hydroxyethylamines |
| 09/30/2004 | US20040192954 Protected tyrosine derivatives, method for the production thereof and use of the same for producing o-(2-[18f]-fluoroethyl)-l-tyrosine |
| 09/30/2004 | US20040192703 Preferentially substituted calcium channel blockers |
| 09/30/2004 | US20040192681 N-acylsulfonamide apoptosis promoters |
| 09/30/2004 | DE10312562A1 Verfahren zur kontinuierlichen Herstellung von Acetalen von α,β-Dicarbonylverbindungen Process for the continuous preparation of acetals of α, β-dicarbonyl compounds |
| 09/30/2004 | CA2519582A1 Substituted p-diaminobenzene derivatives |
| 09/29/2004 | EP1461311A2 Urea derivatives as vr1-antagonists |
| 09/29/2004 | EP1307436B1 Process for the preparation of baccatin iii derivatives |
| 09/29/2004 | EP1189881B1 Propanoic acid derivatives that inhibit the binding of integrins to their receptors |
| 09/29/2004 | CN1533374A Substitutled cyclohexane-1,4-diamine derivatives |
| 09/29/2004 | CN1533270A Oral administered dosage form of GABA anolog prodrugs having reduced toxicity |
| 09/28/2004 | US6797731 Resorcinol derivatives |
| 09/28/2004 | US6797726 N-alkoxyalkyl-N,N-dialkylamine derivatives or salts thereof, and remedies for nerve degeneration diseases containing the same |
| 09/23/2004 | WO2004080492A1 Methods of radiofluorination of biologically active vectors |
| 09/23/2004 | WO2004080480A1 Pharmaceutical preparations comprising acid-stabilised insulin |
| 09/23/2004 | WO2004080377A2 Kcnq channel modulating compounds and their pharmaceutical use |
| 09/23/2004 | WO2004064723A3 Inhibitors and methods of use thereof |
| 09/23/2004 | WO2004050613A3 2-substituted-3-propenamide derivatives and methods of using the same |
| 09/23/2004 | US20040186304 via industrial scale countercurrent thin film evaporator which reacts ketones with alcohols |
| 09/23/2004 | US20040186169 for inhibition of the insulin-like growth factor-1 receptor (IGF-1R); for treatment of IGF-IR dependent diseases, such as cancer, psoriasis, artherosclerosis and acromegaly; picropodophyllin |
| 09/23/2004 | CA2518889A1 Methods of radiofluorination of biologically active vectors |
| 09/22/2004 | EP1460052A1 Process for the continuous preparation of acetals of alpha,beta-dicarbonyl compounds |
| 09/22/2004 | EP1458724A1 Total synthesis of galanthamine, analogues and derivatives thereof |
| 09/22/2004 | EP1458704A1 Aminoindane derivatives as serotonin and norepinephrine uptake inhibitors |
| 09/22/2004 | EP1458676A2 Compounds for the treatment of inflammatory disorders |
| 09/22/2004 | CN1530364A Method for preserving cyclic condensed formol |
| 09/22/2004 | CN1167673C Fluorovinyloxyacetamides, process for preparing the same and herbicidal composition comprising the same |
| 09/21/2004 | US6794545 Conformationally restricted polyamine analogs as disease therapies |
| 09/21/2004 | US6794544 Method for the preparation of tetrahydrobenzothiepines |
| 09/21/2004 | US6794541 Thiourea and urea liquid-phase combinatorial libraries: synthesis and apoptosis induction |
| 09/21/2004 | US6794534 Synthesis of functionalized and unfunctionalized olefins via cross and ring-closing metathesis |
| 09/21/2004 | US6794492 N-(2,2,2-trifluoroethyl)glycine derivatives; can be used to prepare lipophilic proteins adapted for crossing the blood brain barrier |
| 09/16/2004 | WO2004078144A2 Diphenylethylene compounds and uses thereof |
| 09/16/2004 | WO2004064972A9 Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions |
| 09/16/2004 | US20040180964 anti-obestic activity; Neuropeptide Y antagonist |
| 09/16/2004 | US20040180936 having an inhibitory activity on calpains and/or a trapping activity on reactive oxygen species; inflammatory and immunological diseases; disorders of the central or peripheral nervous system |
| 09/16/2004 | US20040180829 Compounds and methods for regulating bacterial growth and pathogenesis |
| 09/16/2004 | CA2517886A1 Diphenylethylene compounds and uses thereof |
| 09/15/2004 | EP1456170A1 Aminoacetonitrile derivatives and their use for controlling parasites |
| 09/15/2004 | EP1341746B1 Liquid crystalline compounds |
| 09/15/2004 | EP1181263B1 Treatment of a composition comprising a trimethylolalkane bis-monolinear formal |
| 09/15/2004 | EP0986384A4 Inhibitors of protein isoprenyl transferases |
| 09/15/2004 | EP0947498B1 Optically active nitro alcohol derivatives, optically active amino alcohol derivatives, and process for preparing the same |
| 09/15/2004 | CN1166659C Novel hetero naphthenic benzcyclobutane and heterocyclo acryl benzcyclobutane compound, their prepn. method and pharmaceutical composites |
| 09/14/2004 | US6790979 Use as antitumor agents, particularly for the treatment of cancers such as colon, skin and prostate cancer and to induce androgen receptor antagonist activity in subject with androgen-related affliction |
| 09/14/2004 | US6790852 Heterocyclic nitrogen compounds such as 2-(2,6-dichlorophenyl) -4-(3-bromophenyl)-5-(2-(3- hydroxypropylamino)pyrimidin-4-yl) -n-h-imidazole, used as tyrosine kinase inhibitors; anticarcinogenic or antitumor agents |
| 09/14/2004 | CA2103110C Insecticidal n'-substituted-n,n'-diacylhydrazines |
| 09/10/2004 | WO2004077511A2 (meth)acrylic and (meth)acrylamide monomers, polymerizable compositions, and polymers obtained |
| 09/10/2004 | WO2004076439A1 Method for producing 4-fluoro-1,3-dioxolan-2-one |
| 09/10/2004 | WO2004076434A1 Dipeptidyl peptidase inhibitors |
| 09/10/2004 | WO2004076433A1 Dipeptidyl peptidase inhibitors |
| 09/10/2004 | WO2004076423A1 Growth promotion method |
| 09/10/2004 | WO2004056755A3 Compounds for the inhibition of non-proteolytic enzymes |
| 09/10/2004 | WO2004022523A3 1, 3-diamino-2-hydroxypropane prodrug derivatives |
| 09/10/2004 | WO2003079984A3 Substituted tetracycline compounds |
| 09/10/2004 | CA2517575A1 Growth promotion method |
| 09/09/2004 | US20040176595 Glucocorticoid receptor modulators |
| 09/09/2004 | US20040176462 NPY Y5 antagonist |
| 09/09/2004 | US20040176461 Sulfonyl-amino or carbonyl-amino derivatives; osteoporosis bone disorders; therapeutic drug or kits including anti-resorptive agents, anabolic agents; |
| 09/09/2004 | US20040176414 principle metabolite of cisapride; has both 5-HT3 antagonistic and 5-HT4 agonistic; devoid of central nervous system effects; separating racemic mixture by liquid chromatography over a chiral stationary phase |
| 09/09/2004 | US20040176384 inhibit Tissue factor expression and vascular permeability factor expression in cancer cells and in vascular endothelial cells in the tumor microenvironment; low toxicity to normal vascular endothelial cells |
| 09/09/2004 | DE10308149A1 Verfahren zur Herstellung von 4-Fluor-1, 3-dioxolan-2-on A process for the preparation of 4-fluoro-1, 3-dioxolan-2-one |
| 09/08/2004 | EP1454893A1 Illudin analogs useful as antitumor agents |
| 09/08/2004 | EP1453869A2 Microstructure modifier for anionic polymerization |
| 09/08/2004 | EP1453789A2 N,n'-substituted-1,3-diamino-2-hydroxypropane derivatives |
| 09/08/2004 | EP1165505B1 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds |
| 09/08/2004 | CN1526711A Synthesis process of important intermediate for anticancer medicine Gemcitabine |
| 09/08/2004 | CN1165508C Methyl oxirane dibenzoylressorinol UV absorbers |
| 09/07/2004 | US6787569 Therapeutic guanidines |
| 09/07/2004 | US6787559 Sulfonamide compounds |
| 09/07/2004 | CA2105709C Substituted cyclohexane derivatives, processes for their preparation and the use of the compounds for treating diseases |
| 09/02/2004 | WO2004073709A1 Antimicrobial agents |
| 09/02/2004 | WO2003102536A3 Destructible surfactants and uses thereof |
| 09/02/2004 | US20040171881 N,N'-substituted-1,3-diamino-2-hydroxypropane derivatives |
| 09/02/2004 | US20040171833 Ligands for metals and improved metal-catalyzed processes based thereon |
| 09/02/2004 | US20040171491 Substituted benzoylcyclohexenones and their use as herbicidal agents |
| 09/01/2004 | EP1452521A1 Cyclic compound and ppar agonist |
| 09/01/2004 | EP1451144A1 Compositions for treating acne comprising phytandiol amine |
| 09/01/2004 | EP1228024B1 Novel hydronaphthalene compounds, prepared by a rhodium catalyzed ring opening reaction in the presence of phosphine ligand |
| 09/01/2004 | CN1525959A Muller Klaus-helmut |
| 09/01/2004 | CN1525955A Carboxamide-substituted phenylurea derivatives, process for their preparation and their use as medicaments |
| 09/01/2004 | CN1164585C Xanthiphenyl ketamine or its salt and its preparing process |
| 08/31/2004 | US6784299 Substituted aromatic ethers as inhibitors of glycine transport |
| 08/31/2004 | US6784292 Method for the production of imidazo-(1,2-C)(2,3)-benzodiazepines and intermediates in the production thereof |
| 08/31/2004 | US6784210 Decyclization of oxabenzonorbornadienes or azabicyclic compounds in the presence of catalysts to form naphthalenes, such as 2-methoxy-1,2-dihydronaphthalen-1-ol, used as analgesics, anticarcinogens or viricides; catalysis |
| 08/31/2004 | US6784173 Aromatic dicarboxylic acid derivatives |
| 08/26/2004 | WO2004072091A1 Glycolipid derivatives, process for production of the same, intermediates for synthesis thereof, and process for production of the intermediates |
| 08/26/2004 | WO2004072087A2 Metal complexes as light-absorbing compounds in the information layer of optical data carriers |
| 08/26/2004 | WO2004071481A1 Melanogenesis inhibitor and skin preparation containing the same |
| 08/26/2004 | WO2004071401A2 Hydroxamic acid derivatives as histone deacetylase inhibitors (hdca) |
| 08/26/2004 | US20040167208 Anticancer agents; arteriosclerosis; psoriasis |
| 08/26/2004 | US20040167126 Such as (2RS,3R)-3-amino-4-cyclohexyl-2-hydroxy-N-phenoxybutanamide; methionine aminopeptidase type 2 inhibitors |
| 08/26/2004 | US20040167100 Illudin analogs useful as antitumor agents |
| 08/26/2004 | DE10125567B4 Carbonamid substituierte Phenylharnstoffderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel Carboxamide-substituted phenylurea derivatives, processes for their preparation and their use as medicaments |
| 08/26/2004 | CA2515396A1 New glycolipids and synthetic method thereof as well as their synthetic intermediates,and synthetic method thereof |
| 08/25/2004 | EP1449834A2 Inhibition of raf kinase using symmetrical and unsymmetrical substituted diphenyl ureas |
| 08/25/2004 | EP1448514A1 Novel alpha-oxygenated or alpha-thiolated carboxylic acid phenethylamide derivatives |
| 08/25/2004 | EP1448181A1 Pharmaceutical composition comprising a combination of metformin and a 4-oxobutanoic acid, and the use thereof for treating diabetes |